What are the major opportunities in the Immunology Biosimilars market? What are the strategies for the Immunology Biosimilars market?

For detailed insights on the major opportunities and strategies in the Immunology Biosimilars market, Read More

How does the Immunology Biosimilars market relate to the overall economy and other similar markets?

For detailed insights on Immunology Biosimilars's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Immunology Biosimilars market growth? SWOT analysis of the Immunology Biosimilars market.

For detailed insights on the key dynamics influencing the Immunology Biosimilars market growth and SWOT analysis of the Immunology Biosimilars industry, Read More

Immunology Biosimilars Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Immunology Biosimilars Market Report 2026

Name: Immunology Biosimilars Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Monoclonal Antibodies, Fusion Proteins, Recombinant Proteins, Interferons, Other Biosimilar Immunomodulators), By Disease (Inflammatory Bowel Disease, Arthritis, Other Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By End User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers (ASCs)) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Immunology Biosimilars Market Overview

• Immunology Biosimilars market size has reached to $8.35 billion in 2025

• Expected to grow to $15.3 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%

• Growth Driver: Rising Prevalence Of Chronic Immunological Conditions Fueling The Growth Of The Market Due To Growing Need For Long-Term Disease Management

• Market Trend: Advancements In Next-Generation Biosimilars Drive Improved Patient Access And Treatment Options

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Immunology Biosimilars Market?

Immunology biosimilars are biologic medical products that are highly similar to already approved original biologic drugs used to treat immune-related diseases, with no significant differences in safety, purity, or potency. It provides more affordable treatment options for patients suffering from conditions such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease, helping to increase access to essential therapies.

The main drug types of immunology biosimilars are monoclonal antibodies, fusion proteins, recombinant proteins, interferons, and others. Monoclonal antibodies are laboratory-produced molecules designed to mimic the immune system's ability to fight off harmful pathogens such as viruses or bacteria. The multiple diseases are inflammatory bowel disease, arthritis, and others. The various distribution channels involved are hospital pharmacies, retail pharmacies, online pharmacies, and others, and they are used by several end users such as hospitals, clinics, homecare settings, and ambulatory surgical centers (ASCs).

Immunology Biosimilars Market Global Report 2026 Market Report bar graph

What Is The Immunology Biosimilars Market Size and Share 2026?

The immunology biosimilars market size has grown rapidly in recent years. It will grow from $8.35 billion in 2025 to $9.45 billion in 2026 at a compound annual growth rate (CAGR) of 13.2%. The growth in the historic period can be attributed to high cost of original biologics, limited availability of biosimilar alternatives, growing prevalence of autoimmune diseases, increasing hospital and clinical adoption of biologics, stringent regulatory approvals for biosimilars.

What Is The Immunology Biosimilars Market Growth Forecast?

The immunology biosimilars market size is expected to see rapid growth in the next few years. It will grow to $15.3 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to development of advanced biosimilar molecules, expansion of homecare and outpatient treatment options, increasing regulatory harmonization, rising patient awareness and acceptance, growth of online and hospital pharmacy distribution channels. Major trends in the forecast period include rising adoption of monoclonal antibody biosimilars, increasing use of fusion protein biosimilars, expansion of recombinant protein therapies, growing market for interferon-based treatments, enhanced access to affordable immunology therapies.

Book your 30 minutes free consultation with our research experts

Global Immunology Biosimilars Market Segmentation

1) By Drug Type: Monoclonal Antibodies, Fusion Proteins, Recombinant Proteins, Interferons, Other Biosimilar Immunomodulators

2) By Disease: Inflammatory Bowel Disease, Arthritis, Other Diseases

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

4) By End User: Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers (ASCs)

Subsegments:

1) By Monoclonal Antibodies: Anti-Tumor Necrosis Factor Agents, Anti-Interleukin-6 Agents, Anti-Cluster of Differentiation 20 Agents, Anti-Interleukin-12/23 Agents, Other Monoclonal Antibodies

2) By Fusion Proteins: Etanercept Biosimilars, Other Fusion Protein Biosimilars

3) By Recombinant Proteins: Recombinant Human Insulin, Recombinant Human Growth Hormone, Recombinant Human Erythropoietin, Other Recombinant Protein Biosimilars

4) By Interferons: Interferon Alpha, Interferon Beta, Interferon Gamma

5) By Other Biosimilar Immunomodulators: Interleukin Inhibitors, Janus Kinase Inhibitors, Other Immunomodulatory Biosimilars

What Is The Driver Of The Immunology Biosimilars Market?

The increasing prevalence of chronic immunological conditions is expected to propel the growth of the immunology biosimilars market going forward. Chronic immunological conditions are long-lasting disorders in which the immune system malfunctions, either attacking the body’s tissues or failing to protect it effectively. The rise in chronic immunological conditions is due to the growing number of individuals affected by long-term immune system disorders that require continuous treatment, proactive disease management, and ongoing healthcare support. Immunology biosimilars support chronic immunological conditions by providing affordable and effective treatment alternatives, supporting long-term disease management, and improving patient access to essential therapies that control immune system dysfunction. For instance, in November 2023, according to the Multiple Sclerosis International Federation (MSIF), a UK-based international nonprofit organization, global MS research and advocacy, an estimated 2.9 million people worldwide were living with multiple sclerosis in 2023. Therefore, the increasing prevalence of chronic immunological conditions is driving growth in the immunology biosimilars industry.

Key Players In The Global Immunology Biosimilars Market

Major companies operating in the immunology biosimilars market are Pfizer Inc., Novartis AG, Amgen Inc., Sandoz Group AG, Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Samsung Bioepis Co. Ltd., Gedeon Richter Plc, Celltrion Inc., Biocon Ltd., Innovent Biologics Inc., Biocad, Mabion S.A.

Global Immunology Biosimilars Market Trends and Insights

Major companies operating in the immunology biosimilars market are focusing on the development of next-generation biosimilar innovations, such as anticipated interchangeability designation, advanced formulations with enhanced stability, and novel delivery systems, to provide patients with more accessible and effective treatment options. Anticipated interchangeability designation means the biosimilar is expected to meet regulatory standards, allowing it to be substituted for the reference biologic at the pharmacy level without the prescriber’s intervention. For instance, in February 2025, Sandoz Group AG, a Switzerland-based pharmaceutical company, launched Pyzchiva (ustekinumab-ttwe), a biosimilar to Stelara, for the treatment of chronic autoimmune conditions including plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis. The launch, in partnership with Samsung Bioepis Co. Ltd., a South Korea-based biopharmaceutical company, reinforces Sandoz’s commitment to expanding access to immunology biosimilars by offering a cost-effective and patient-centric therapy with multiple dosing options, extended stability, and the unique ability to be re-refrigerated after initial refrigeration.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Immunology Biosimilars Market?

In February 2025, Accord BioPharma Inc., a U.S.-based healthcare company, partnered with Bio-Thera Solutions Co., Ltd. for BAT2506, a proposed golimumab biosimilar. With this agreement, Accord BioPharma, Inc. aimed to expand its immunology biosimilar portfolio in the U.S. by obtaining commercialization rights for a late-stage TNF-a–blocking biosimilar. Bio-Thera Solutions Co. Ltd. is a China-based biopharmaceutical company that specializes in developing, manufacturing, and supplying innovative biosimilars, including immunology assets such as BAT2506.

Regional Insights

North America was the largest region in the immunology biosimilars market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Immunology Biosimilars Market?

The immunology biosimilars market consists of sales of tumor necrosis factor inhibitors, recombinant cytokines, t-cell co-stimulation modulators, and monoclonal antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Immunology Biosimilars Market Report 2026?

The immunology biosimilars market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the immunology biosimilars industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Immunology Biosimilars Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$9.45 billion
Revenue Forecast In 2035	$15.3 billion
Growth Rate	CAGR of 13.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Disease, Distribution Channel, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Novartis AG, Amgen Inc., Sandoz Group AG, Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Samsung Bioepis Co. Ltd., Gedeon Richter Plc, Celltrion Inc., Biocon Ltd., Innovent Biologics Inc., Biocad, Mabion S.A.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Immunology Biosimilars Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Immunology Biosimilars Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Immunology Biosimilars Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Immunology Biosimilars Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Rising Adoption Of Monoclonal Antibody Biosimilars

4.2.2 Increasing Use Of Fusion Protein Biosimilars

4.2.3 Expansion Of Recombinant Protein Therapies

4.2.4 Growing Market For Interferon-Based Treatments

4.2.5 Enhanced Access To Affordable Immunology Therapies

5. Immunology Biosimilars Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Clinics

5.3 Homecare Settings

5.4 Ambulatory Surgical Centers (Ascs)

5.5 Specialty Care Centers

6. Immunology Biosimilars Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Immunology Biosimilars Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Immunology Biosimilars PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Immunology Biosimilars Market Size, Comparisons And Growth Rate Analysis

7.3. Global Immunology Biosimilars Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Immunology Biosimilars Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Immunology Biosimilars Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Immunology Biosimilars Market Segmentation

9.1. Global Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Monoclonal Antibodies, Fusion Proteins, Recombinant Proteins, Interferons, Other Biosimilar Immunomodulators

9.2. Global Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inflammatory Bowel Disease, Arthritis, Other Diseases

9.3. Global Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.4. Global Immunology Biosimilars Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers (ASCs)

9.5. Global Immunology Biosimilars Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Tumor Necrosis Factor Agents, Anti-Interleukin-6 Agents, Anti-Cluster of Differentiation 20 Agents, Anti-Interleukin-12/23 Agents, Other Monoclonal Antibodies

9.6. Global Immunology Biosimilars Market, Sub-Segmentation Of Fusion Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Etanercept Biosimilars, Other Fusion Protein Biosimilars

9.7. Global Immunology Biosimilars Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Human Insulin, Recombinant Human Growth Hormone, Recombinant Human Erythropoietin, Other Recombinant Protein Biosimilars

9.8. Global Immunology Biosimilars Market, Sub-Segmentation Of Interferons, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interferon Alpha, Interferon Beta, Interferon Gamma

9.9. Global Immunology Biosimilars Market, Sub-Segmentation Of Other Biosimilar Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Interleukin Inhibitors, Janus Kinase Inhibitors, Other Immunomodulatory Biosimilars

10. Immunology Biosimilars Market Regional And Country Analysis

10.1. Global Immunology Biosimilars Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Immunology Biosimilars Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Immunology Biosimilars Market

11.1. Asia-Pacific Immunology Biosimilars Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Immunology Biosimilars Market

12.1. China Immunology Biosimilars Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Immunology Biosimilars Market

13.1. India Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Immunology Biosimilars Market

14.1. Japan Immunology Biosimilars Market Overview

14.2. Japan Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Immunology Biosimilars Market

15.1. Australia Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Immunology Biosimilars Market

16.1. Indonesia Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Immunology Biosimilars Market

17.1. South Korea Immunology Biosimilars Market Overview

17.2. South Korea Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Immunology Biosimilars Market

18.1. Taiwan Immunology Biosimilars Market Overview

18.2. Taiwan Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Immunology Biosimilars Market

19.1. South East Asia Immunology Biosimilars Market Overview

19.2. South East Asia Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Immunology Biosimilars Market

20.1. Western Europe Immunology Biosimilars Market Overview

20.2. Western Europe Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Immunology Biosimilars Market

21.1. UK Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Immunology Biosimilars Market

22.1. Germany Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Immunology Biosimilars Market

23.1. France Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Immunology Biosimilars Market

24.1. Italy Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Immunology Biosimilars Market

25.1. Spain Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Immunology Biosimilars Market

26.1. Eastern Europe Immunology Biosimilars Market Overview

26.2. Eastern Europe Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Immunology Biosimilars Market

27.1. Russia Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Immunology Biosimilars Market

28.1. North America Immunology Biosimilars Market Overview

28.2. North America Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Immunology Biosimilars Market

29.1. USA Immunology Biosimilars Market Overview

29.2. USA Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Immunology Biosimilars Market

30.1. Canada Immunology Biosimilars Market Overview

30.2. Canada Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Immunology Biosimilars Market

31.1. South America Immunology Biosimilars Market Overview

31.2. South America Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Immunology Biosimilars Market

32.1. Brazil Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Immunology Biosimilars Market

33.1. Middle East Immunology Biosimilars Market Overview

33.2. Middle East Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Immunology Biosimilars Market

34.1. Africa Immunology Biosimilars Market Overview

34.2. Africa Immunology Biosimilars Market, Segmentation By Drug Type, Segmentation By Disease, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Immunology Biosimilars Market Regulatory and Investment Landscape

36. Immunology Biosimilars Market Competitive Landscape And Company Profiles

36.1. Immunology Biosimilars Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Immunology Biosimilars Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Immunology Biosimilars Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

37. Immunology Biosimilars Market Other Major And Innovative Companies

Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Samsung Bioepis Co. Ltd., Gedeon Richter Plc, Celltrion Inc., Biocon Ltd., Innovent Biologics Inc., Biocad, Mabion S.A.

38. Global Immunology Biosimilars Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Immunology Biosimilars Market

40. Immunology Biosimilars Market High Potential Countries, Segments and Strategies

40.1 Immunology Biosimilars Market In 2030 - Countries Offering Most New Opportunities

40.2 Immunology Biosimilars Market In 2030 - Segments Offering Most New Opportunities

40.3 Immunology Biosimilars Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Immunology Biosimilars Market, Overview Of Key Products - Product Examples

Table 2: Global Immunology Biosimilars Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Immunology Biosimilars Market, Supply Chain Analysis

Table 4: Global Immunology Biosimilars Market, Major Raw Material Providers

Table 5: Global Immunology Biosimilars Market, Major Resource Providers

Table 6: Global Immunology Biosimilars Market, Major Manufacturers (Suppliers)

Table 7: Global Immunology Biosimilars Market, Major Distributors And Channel Partners

Table 8: Global Immunology Biosimilars Market, Key Technologies & Future Trends

Table 9: Global Immunology Biosimilars Market, Major Trends

Table 10: Global Immunology Biosimilars Market, Major End Users

Table 11: Global Immunology Biosimilars Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Immunology Biosimilars Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Immunology Biosimilars Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Immunology Biosimilars Market - TAM, US$ Billion, 2025

Table 15: Global Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Immunology Biosimilars Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Immunology Biosimilars Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Immunology Biosimilars Market, Sub-Segmentation Of Fusion Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Immunology Biosimilars Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Immunology Biosimilars Market, Sub-Segmentation Of Interferons, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Immunology Biosimilars Market, Sub-Segmentation Of Other Biosimilar Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Immunology Biosimilars Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Immunology Biosimilars Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Immunology Biosimilars Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Immunology Biosimilars Market - Company Scoring Matrix

Table 100: Pfizer Inc. Financial Performance

Table 101: Novartis AG Financial Performance

Table 102: Amgen Inc. Financial Performance

Table 103: Sandoz Group AG Financial Performance

Table 104: Fresenius Kabi AG Financial Performance

Table 105: Global Immunology Biosimilars Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Immunology Biosimilars Market, Competitive Dashboard

Table 107: Global Immunology Biosimilars Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Immunology Biosimilars Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 109: Global, Immunology Biosimilars Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Table 110: Global, Immunology Biosimilars Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

List Of Figures

Figure 1: Global Immunology Biosimilars Market, Overview Of Key Products - Product Examples

Figure 2: Global Immunology Biosimilars Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Immunology Biosimilars Market, Supply Chain Analysis

Figure 4: Global Immunology Biosimilars Market, Major Raw Material Providers

Figure 5: Global Immunology Biosimilars Market, Major Resource Providers

Figure 6: Global Immunology Biosimilars Market, Major Manufacturers (Suppliers)

Figure 7: Global Immunology Biosimilars Market, Major Distributors And Channel Partners

Figure 8: Global Immunology Biosimilars Market, Key Technologies & Future Trends

Figure 9: Global Immunology Biosimilars Market, Major Trends

Figure 10: Global Immunology Biosimilars Market, Major End Users

Figure 11: Global Immunology Biosimilars Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Immunology Biosimilars Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Immunology Biosimilars Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Immunology Biosimilars Market - TAM, US$ Billion, 2025

Figure 15: Global Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Immunology Biosimilars Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Immunology Biosimilars Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Immunology Biosimilars Market, Sub-Segmentation Of Fusion Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Immunology Biosimilars Market, Sub-Segmentation Of Recombinant Proteins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Immunology Biosimilars Market, Sub-Segmentation Of Interferons, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Immunology Biosimilars Market, Sub-Segmentation Of Other Biosimilar Immunomodulators, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Immunology Biosimilars Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Immunology Biosimilars Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Immunology Biosimilars Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Immunology Biosimilars Market, Segmentation By Disease, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Immunology Biosimilars Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Immunology Biosimilars Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Immunology Biosimilars Market - Company Scoring Matrix

Figure 100: Pfizer Inc. Financial Performance

Figure 101: Novartis AG Financial Performance

Figure 102: Amgen Inc. Financial Performance

Figure 103: Sandoz Group AG Financial Performance

Figure 104: Fresenius Kabi AG Financial Performance

Figure 105: Global Immunology Biosimilars Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Immunology Biosimilars Market, Competitive Dashboard

Figure 107: Global Immunology Biosimilars Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Immunology Biosimilars Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 109: Global, Immunology Biosimilars Market Size Gain ($ Billion), Segmentation By Disease, 2025 – 2030

Figure 110: Global, Immunology Biosimilars Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Immunomodulator Market Report 2026 - Global Outlook – By Product Type (Immunosuppressants, Immunostimulants, Other Product Types), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distr...

Biosimilars Market Report 2026 - Global Outlook – By Type (Monoclonal Antibodies, Insulin, Erythropoietin, Granulocyte-Colony Stimulating Factor, Other Hormones), By Protein Type (Recombinant Non-glycosylated Proteins, R...

Bevacizumab Biosimilars Market Report 2026 - Global Outlook – By Product (Avastin, Mvasi, Zirabev, Aybintio, Other Products), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other Distributi...

Automated Immunoassay Analyzers Market Report 2026 - Global Outlook – By Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System (ELISA), Multiplexed Assay System, Radioimmunoassay), By Applicati...

Immunoassay Market Report 2026 - Global Outlook – By Product (Reagents And Kits, Analyzers Or Instruments, Software And Services), By Specimen (Blood, Saliva, Urine, Other Specimens), By Application (Therapeutic Drug Mon...

Immunohematology Market Report 2026 - Global Outlook – By Product (Analyzers And Systems, Reagents), By Technology (Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PC...

Frequently Asked Questions

How big is the Immunology Biosimilars Market?

The Immunology Biosimilars market was valued at $8.35 billion in 2025, increased to $9.45 billion in 2026, and is projected to reach $15.3 billion by 2030.

What is the Immunology Biosimilars market growth?

The global Immunology Biosimilars market is expected to grow at a CAGR of 12.8% from 2026 to 2035 to reach $15.3 billion by 2035.

Who are the key players in Immunology Biosimilars market?

Some Key Players in the Immunology Biosimilars market Include, Pfizer Inc., Novartis AG, Amgen Inc., Sandoz Group AG, Fresenius Kabi AG, Intas Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Samsung Bioepis Co. Ltd., Gedeon Richter Plc, Celltrion Inc., Biocon Ltd., Innovent Biologics Inc., Biocad, Mabion S.A. .

What is the anticipated growth trend for the Immunology Biosimilars market?

Major trend in this market includes: Advancements In Next-Generation Biosimilars Drive Improved Patient Access And Treatment Options. For further insights on this market. request a sample here

Which region has the most growth potential in the Immunology Biosimilars market?

North America was the largest region in the immunology biosimilars market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunology biosimilars market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.